Caspase inhibitor Emricasan, Purity ≥98%

Synonym: 254750-02-2; IDN-6556; PF-03491390; Emricasan; PF 03491390; (S)-3-((S)-2-(2-((2-(tert-Butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid; Caspase inhibitor

CAS Number: 254750-02-2
Compound CID: 12000240

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Emricasan, soluble in DMSO and ethanol and insoluble in water, inhibits the activity of caspases, thereby preventing apoptosis. It targets Caspase.

Molecular Weight

569.5

Molecular Formula

C₂₆H₂₇F₄N₃O₇

Targets

Caspase

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 97 mg/mL (170.32 mM); Water: Insoluble; Ethanol: 97 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Emricasan can be used to inhibit pan-caspases, providing insights into the therapeutic potential for treating liver diseases and other conditions involving excessive apoptosis.

Storage

Store at -20ºC.